Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Opus Genetics (IRD) Interest Expenses (2020 - 2026)

Opus Genetics has reported Interest Expenses over the past 5 years, most recently at $69000.0 for Q1 2026.

  • Quarterly Interest Expenses changed N/A to $69000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $198000.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $129000.0 for FY2025, N/A changed from the prior year.
  • Interest Expenses was $69000.0 for Q1 2026 at Opus Genetics, up from $61000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $69000.0 in Q1 2026 and troughed at $4000.0 in Q2 2022.
  • The 3-year median for Interest Expenses is $61000.0 (2025), against an average of $41400.0.